Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
enrofloxacin (UNII: 3DX3XEK1BN) (enrofloxacin - UNII:3DX3XEK1BN)
BUTLER ANIMAL HEALTH SUPPLY, LLC dba COVETRUS NORTH AMERICA
SUBCUTANEOUS
PRESCRIPTION
Cattle - Single-Dose Therapy: Enrofloxacin 100 Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Cattle - Multiple-DayTherapy: Enrofloxacin 100 Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle. Swine: Enrofloxacin 100 Injection is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. Enrofloxacin 100 injection is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with Escherichia coli has been diagnosed.
Enrofloxacin 100 Injection:
Abbreviated New Animal Drug Application
ENROFLOXACIN 100- ENROFLOXACIN INJECTION, SOLUTION BUTLER ANIMAL HEALTH SUPPLY, LLC DBA COVETRUS NORTH AMERICA ---------- COVETRUS Approved by FDA under ANADA # 200-495 ENROFLOXACIN 100 INJECTION (ENROFLOXACIN) 100 MG/ML ANTIMICROBIAL INJECTABLE SOLUTION For Subcutaneous Use In Beef Cattle And Non-Lactating Dairy Cattle For Intramuscular Or Subcutaneous Use In Swine Not For Use In Female Dairy Cattle 20 Months Of Age Or Older Or In Calves To Be Processed For Veal CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options. PRODUCT DESCRIPTION: Enrofloxacin 100 Injection is a sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent. Each mL of Enrofloxacin 100 Injection contains 100 mg of enrofloxacin. Excipients are L-arginine base 200 mg, n-butyl alcohol 30 mg, benzyl alcohol (as a preservative) 20 mg and water for injection q.s. CHEMICAL NOMENCLATURE AND STRUCTURE: 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid. INDICATIONS: CATTLE - SINGLE-DOSE THERAPY: Enrofloxacin 100 Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with _Mannheimia haemolytica,_ ® _Pasteurella multocida, Histophilus somni_ and _Mycoplasma bovis_ in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with _M. haemolytica, P. multocida, H. somni_ and _M. bovis._ CATTLE - MULTIPLE-DAYTHERAPY: Enrofloxacin 100 Injection is indicated for the treatment of bovine respiratory disease (BRD) associated with _Mannheimia haemolytica,_ _Pasteurella multocida_ and _Histophilus somni_ in Přečtěte si celý dokument